BRKB

489.25

+0.41%↑

BRKA.US

733,498

+0.38%↑

JPM

311.63

+0.78%↑

V

340.32

+0.32%↑

MA

554.03

+0.25%↑

BRKB

489.25

+0.41%↑

BRKA.US

733,498

+0.38%↑

JPM

311.63

+0.78%↑

V

340.32

+0.32%↑

MA

554.03

+0.25%↑

BRKB

489.25

+0.41%↑

BRKA.US

733,498

+0.38%↑

JPM

311.63

+0.78%↑

V

340.32

+0.32%↑

MA

554.03

+0.25%↑

BRKB

489.25

+0.41%↑

BRKA.US

733,498

+0.38%↑

JPM

311.63

+0.78%↑

V

340.32

+0.32%↑

MA

554.03

+0.25%↑

BRKB

489.25

+0.41%↑

BRKA.US

733,498

+0.38%↑

JPM

311.63

+0.78%↑

V

340.32

+0.32%↑

MA

554.03

+0.25%↑

Search

Hercules Capital Inc

Fermé

SecteurFinance

18.07 0.72

Résumé

Variation du prix de l'action

24h

Actuel

Min

17.75

Max

18.1

Chiffres clés

By Trading Economics

Revenu

-56M

1.8M

Ventes

37M

117M

P/E

Moyenne du Secteur

10.236

26.975

BPA

0.49

Rendement du dividende

8.93

Marge bénéficiaire

1.519

Employés

100

EBITDA

-39M

63M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+11.74% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

8.93%

3.92%

Date du Prochain Dividende

19 nov. 2025

Date du Prochain Détachement de Dividende

12 nov. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-28M

3.2B

Ouverture précédente

17.35

Clôture précédente

18.07

Sentiment de l'Actualité

By Acuity

100%

0%

504 / 528 Classement par Finance

Score Technique

By Trading Central

Confiance

Neutral Evidence

Hercules Capital Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

5 nov. 2025, 23:51 UTC

Résultats

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

5 nov. 2025, 23:10 UTC

Résultats

DBS Third Quarter Net Dips 2.0%

5 nov. 2025, 22:55 UTC

Résultats

Arm Holdings 2Q Profit Climbs on Record Demand

5 nov. 2025, 22:23 UTC

Résultats

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

5 nov. 2025, 23:52 UTC

Résultats

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

5 nov. 2025, 23:49 UTC

Résultats

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

5 nov. 2025, 23:49 UTC

Résultats

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

5 nov. 2025, 23:45 UTC

Market Talk

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

5 nov. 2025, 23:42 UTC

Market Talk

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

5 nov. 2025, 23:12 UTC

Résultats

Nutrien 3Q Adj EPS 97c >NTR.T

5 nov. 2025, 23:11 UTC

Résultats

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

5 nov. 2025, 23:10 UTC

Résultats

Nutrien 3Q Sales $6.01B >NTR.T

5 nov. 2025, 23:10 UTC

Market Talk
Résultats

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

5 nov. 2025, 23:10 UTC

Résultats

Nutrien 3Q EPS 96c >NTR.T

5 nov. 2025, 23:04 UTC

Résultats

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

5 nov. 2025, 23:03 UTC

Market Talk

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

5 nov. 2025, 22:55 UTC

Market Talk

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

5 nov. 2025, 22:55 UTC

Résultats

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

5 nov. 2025, 22:51 UTC

Résultats

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

5 nov. 2025, 22:50 UTC

Résultats

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

5 nov. 2025, 22:44 UTC

Acquisitions, Fusions, Rachats

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5 nov. 2025, 22:43 UTC

Market Talk
Résultats

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

5 nov. 2025, 22:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5 nov. 2025, 22:36 UTC

Market Talk

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

5 nov. 2025, 22:20 UTC

Market Talk

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

5 nov. 2025, 22:12 UTC

Acquisitions, Fusions, Rachats

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5 nov. 2025, 22:11 UTC

Acquisitions, Fusions, Rachats

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5 nov. 2025, 22:11 UTC

Acquisitions, Fusions, Rachats

Pfizer Responds to Delaware Chancery Court Ruling

5 nov. 2025, 22:01 UTC

Résultats

Great-West Lifeco 3Q Net C$1.16B >GWO.T

5 nov. 2025, 22:01 UTC

Résultats

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

Comparaison

Variation de prix

Hercules Capital Inc prévision

Objectif de Prix

By TipRanks

11.74% hausse

Prévisions sur 12 Mois

Moyen 20.08 USD  11.74%

Haut 24 USD

Bas 18 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

6 ratings

5

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

17.41 / 17.93Support & Résistance

Court Terme

Neutral Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Hercules Capital Inc

Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable
help-icon Live chat